A House committee hearing on the Food and Drug Administration's progress toward implementing a federal law requiring it to develop a regulatory strategy for health information technology was postponed last Thursday as the government shutdown continued, according to an article on the Modern Healthcare website.
Dr. Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, was scheduled to testify before the Health Subcommittee of the House Energy and Commerce Committee on the Food and Drug Administration Safety Innovation Act. Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, was also scheduled to testify at the subcommittee hearing.
The 2012 law requires HHS, through the FDA, and in consultation with the Office of the National Coordinator of Health Information Technology and the Federal Communications Commission, to develop "a proposed strategy and recommendations on an appropriate, risk-based regulatory framework pertaining to health information technology, including mobile medical applications, that promotes innovation, protects patient safety and avoids regulatory duplication," according to the article.
Read the article.
Going Solar with No Upfront Costs
Northwell Health Finds Energy Savings in Steam Systems
Endeavor Elmhurst Hospital Opens New 16-Bed Patient Observation Unit
Sustainability as a Baseline in Healthcare Facilities
Penobscot Valley Hospital Reports Data Security Incident